FIM
JSPR icon

Fernwood Investment Management’s Jasper Therapeutics JSPR Stock Holding History

Fernwood Investment Management’s Portfolio JSPR Stock Details JSPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$1.13M Hold
52,897
– – 0.39% 56
2024
Q3 		$995K Buy
52,897
+3,427
+7% +$68.2K 0.32% 74
2024
Q2 		$1.12M Hold
49,470
– – 0.35% 70
2024
Q1 		$1.45M Sell
49,470
-1
-0% -$18 0.42% 61
2023
Q4 		$390K Buy
49,471
+4,000
+9% +$26.8K 0.13% 135
2023
Q3 		$318K Hold
45,471
– – 0.11% 144
2023
Q2 		$623K Hold
45,471
– – 0.22% 99
2023
Q1 		$823K Hold
45,471
– – 0.32% 89
2022
Q4 		$220K Buy
45,471
+15,763
+53% +$106K 0.09% 167
2022
Q3 		$234K Buy
+29,708
New +$544K 0.1% 157

Other funds holding JSPR

SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
QUSVM
Qiming U.S. Ventures Management Bellevue, Washington $55.6M AUM 98.09% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Fernwood Investment Management's JSPR Position: Q4 2024 in Review

Fernwood Investment Management held its Jasper Therapeutics (JSPR) position steady in Q4 2024 at 52,897 shares worth $1.13M. The position accounts for 0.39% of the portfolio, ranked #56.

Fernwood Investment Management first reported a position in JSPR in Q3 2022 and has held it in 10 quarters since. The position peaked at $1.45M in Q1 2024. 87 funds tracked by Wall St. Rank hold JSPR as of Q4 2024.

  • Fernwood Investment Management held 52,897 shares of Jasper Therapeutics worth $1.13M as of Q4 2024.
  • Fernwood Investment Management left its Jasper Therapeutics share count unchanged in Q4 2024.
  • Jasper Therapeutics made up 0.39% of Fernwood Investment Management's portfolio in Q4 2024, its #56 holding.
  • Fernwood Investment Management first reported a position in Jasper Therapeutics in Q3 2022 and has held it in 10 quarters since.
  • Fernwood Investment Management's Jasper Therapeutics position peaked at $1.45M in Q1 2024.
  • 87 funds tracked by Wall St. Rank held Jasper Therapeutics as of Q4 2024.

Based on Fernwood Investment Management's 13F filing for Q4 2024, filed 13 Feb 2025.